USPTO serial 79348513
AVIADOBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 20, 2025
- Examiner
- MAKSHOOD, AKEELA MOHAMED
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AVIADOBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Snider
Matthew J. Snider Dickinson Wright PLLC1825 Eye St., N.W., Suite 900Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; Biotechnological preparations for medical use for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds, namely, liposomes and viral particles that facilitate delivery of a wide range of pharmaceuticals | ACTIVE | — |
| 009 | Downloadable computer software for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; downloadable computer software for analysing clinical information; downloadable computer software for diagnosis of neurological diseases and disorders; downloadable computer software for use in medical instruments and apparatus to manage and analyse medical, scientific and clinical data; downloadable computer software for collecting and exchanging medical, scientific and clinical information and data; downloadable computer software for monitoring medical instruments and apparatus and interfacing with the cloud; electric sensors for monitoring medical instruments and apparatus and interfacing with the cloud; downloadable computer software for mobile devices, smart phones, tablet computers, personal computers and televisions for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; downloadable computer software for transmitting, sharing, receiving, streaming, downloading, playing, organizing, displaying, collecting and transferring medical, scientific and clinical information, data, audio, video, and images between devices via the internet, over a wireless communication networks; downloadable computer software for the remote control of machines and medical instruments and apparatus; downloadable computer application software for cloud computing services for managing virtual machines on a cloud computing platform; computer hardware; computer network hubs, switches and routers; computer network hubs for monitoring medical instruments and apparatus and interfacing with the cloud; touch screens; bioimaging scanners being image scanners; scanners for capturing images for analysis for use in the life science research field; image scanners for capturing bio visual representations of biological processes; wearable telecommunication devices in the nature of activity trackers, smart glasses and smart watches for the wireless receipt, storage and transmission of data and messages; head-mounted video display apparatus being wearable video display units | ACTIVE | — |
| 010 | Medical instruments and apparatus for use in surgery; surgical instruments and apparatus, namely, clamps for surgical use, surgical retractors, surgical platforms, surgical stabilizers, and surgical manipulator arms; medical instruments and apparatus for the diagnosis of neurological diseases and disorders; medical instruments and apparatus, namely, nebulizers for medical purposes, infusion and injection devices for administering drugs, dosage dispensers for administering medicine to patients, catheters, cannulas, needles for medical purposes, surgical tubing for drainage, transfusion, and administering drugs, implantable drug delivery pumps, and implantable drug delivery ports for administering pharmaceutical and biotechnological preparations and substances; medical instruments and apparatus, namely, nebulizers for medical purposes, infusion and injection devices for administering drugs, dosage dispensers for administering medicine to patients, implantable drug delivery pumps, and implantable drug delivery ports for administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological diseases and disorders; implantable drug delivery devices, namely, implantable drug delivery pumps and implantable drug delivery ports | ACTIVE | — |
| 041 | Education services, namely, providing classes, seminars and workshops in the fields of medicine, health, healthcare, wellbeing, clinical trials and clinical information, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders, and distribution of training materials in connection therewith; publication of online electronic publications, namely, journals, periodicals, blogs, and newsletters featuring the results of clinical trials and clinical information; publication of journals, periodicals, printed matter, and newsletters, featuring the results of clinical trials and clinical information; providing medical and scientific online non-downloadable electronic publications in the nature of journals, periodicals, blogs, and newsletters in the fields of medicine, health, healthcare, wellbeing, clinical trials and clinical information, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; providing online non-downloadable electronic publications in the nature of journals, periodicals, blogs, and newsletters, in the fields of medicine, health, healthcare, wellbeing, clinical trials and clinical information, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; providing online non-downloadable videos in the fields of medicine, health, healthcare, wellbeing, clinical trials and clinical information, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; consulting services in the fields of the aforegoing services | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research and design in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; design and development of computer hardware and software; scientific research and development, biological research and development, clinical research and development, and medical research and development, all in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; Pharmaceutical research and development; testing of pharmaceuticals; research, development and testing of biotechnological preparations and substances in the fields of gene therapy, neurosurgery, medical devices, medical imaging, neurology, and neurological, neuromuscular, and neurodegenerative therapeutics, diseases and disorders; research, development and testing of medical and scientific instruments and apparatus in the fields of gene therapy, neurosurgery, medical imaging, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; scientific research and development services, namely, research, development and testing in the fields of neurological therapeutics, diseases and disorders; engineering and scientific research and development services, namely, design and development of medical diagnostic apparatus for detecting and diagnosing neurological, neuromuscular and neurodegenerative diseases and disorders; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical and biotechnological preparations and substances; scientific research in the nature of conducting clinical trials for others in the fields of neurological therapeutics, diseases and disorders; Scientific research in the nature of conducting clinical trials for others in the fields of medical and scientific instruments and apparatus; providing online, non-downloadable software for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for analysing clinical information in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; providing online, non-downloadable software for diagnosis of neurological diseases and disorders; providing online, non-downloadable software for medical instruments and apparatus for use in detecting, diagnosing and treating neurological, neuromuscular and neurodegenerative diseases and disorders; providing online, non-downloadable software for connecting machines and medical instruments and apparatus for use in detecting, diagnosing and treating neurological, neuromuscular and neurodegenerative diseases and disorders; providing online, non-downloadable software for collecting and exchanging medical, scientific and clinical information and data in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; providing online, non-downloadable software for monitoring medical instruments and apparatus and interfacing with the cloud in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, neurology, and neurological and neurodegenerative therapeutics, diseases and disorders; providing online, non-downloadable software for mobile devices, smart phones, tablet computers, personal computers and televisions for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for transmitting, sharing, receiving, streaming, downloading, playing, organizing, displaying, collecting and transferring medical, scientific and clinical information, data, audio, video, and images between devices via the internet, and over wireless communication networks; providing temporary use of online, non-downloadable software for the remote control of machines and medical instruments and apparatus in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; providing online, non-downloadable cloud computing software for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for cloud computing services for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; information technology consulting services relating to the selection, installation, maintenance and repair of computer software designed for use with medical and scientific instruments and apparatus; information technology consulting services relating to the selection, installation, maintenance and repair of computer software designed for use in the fields of pharmaceutical and biotechnological preparations and substances; consulting services in the field of the aforegoing services | ACTIVE | — |
| 044 | Medical services; healthcare services, namely, wellness programs, managed healthcare services, integrated healthcare services with a network of international healthcare providers, Internet-based health care information services, advisory services relating to health care, consultancy services relating to health care, health care services for treating neurological, neuromuscular, and neurodegenerative diseases and disorders, and disease management programs; medical and healthcare services, namely, disease management programs and managed healthcare services; medical and healthcare services, namely, genetic testing for medical, diagnostic and treatment purposes; providing medical and healthcare information; providing health and medical information; providing health and medical information in the field of neurological therapeutics; providing medical and healthcare information services via the Internet; advisory and consulting services in the field of the aforegoing services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AVIADOBIO LTD
- Other trademarks owned by AVIADOBIO LTD
- Other trademarks owned by AVIADOBIO LTD
- Other trademarks owned by AVIADOBIO LTD
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AVIADOBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 11, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 11, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 20, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 20, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 20, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 1, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 1, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 6, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 6, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 6, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 6, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 9, 2024 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Sep 9, 2024 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Sep 9, 2024 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Aug 15, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Feb 26, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 10, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 10, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 10, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 10, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 2, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 2, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 19, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 10, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 29, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 6, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 1, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |